Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
|2||Not yet recruiting||
Influenza Vaccine To Prevent Adverse Vascular Events: A Pilot Study
† Indicates status has not been verified in more than two years